Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: real-life experiences. (Record no. 29283339)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02269 a2200625 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250518020814.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201906s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1473-5687 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1097/MEG.0000000000001334 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Örmeci, Necati |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20190624 |
245 00 - TITLE STATEMENT | |
Title | Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: real-life experiences. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | European journal of gastroenterology & hepatology |
Date of publication, distribution, etc. | 04 2019 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 534-539 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Multicenter Study |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | 2-Naphthylamine |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anilides |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antiviral Agents |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carbamates |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cyclopropanes |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hepacivirus |
General subdivision | isolation & purification |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hepatitis C, Chronic |
General subdivision | complications |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lactams, Macrocyclic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Macrocyclic Compounds |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Proline |
General subdivision | analogs & derivatives |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Renal Insufficiency, Chronic |
General subdivision | complications |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Retrospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ritonavir |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sulfonamides |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sustained Virologic Response |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Uracil |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Valine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sezgin, Orhan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Karaali, Ridvan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Aygen, Bilgehan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Turan, Dilara |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yaras, Serkan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Erdem, İlknur |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yildiz, Orhan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Karakaya, Fatih |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ateş, Kenan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Asiller, Özgün Ö |
773 0# - HOST ITEM ENTRY | |
Title | European journal of gastroenterology & hepatology |
Related parts | vol. 31 |
-- | no. 4 |
-- | p. 534-539 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1097/MEG.0000000000001334">https://doi.org/10.1097/MEG.0000000000001334</a> |
Public note | Available from publisher's website |
No items available.